PGNX - Progenics Pharmaceuticals misses by $0.04 misses on revenue March, 14 2019 07:50 AM Progenics Pharmaceuticals Inc. Progenics Pharmaceuticals (NASDAQ:PGNX): Q4 GAAP EPS of -$0.17 misses by $0.04.More news on: Progenics Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...